Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

MSL Talk

Social Media and Compliance: What Every MSL Should Know

Mar 3, 202632 minVideo
ShareXLinkedInFacebookWhatsAppEmail

In this episode, Tom Caravela and Carl De Luca explore social media compliance for Medical Science Liaisons. They discuss maintaining compliance while ensuring scientific credibility, address misconceptions about promotional activities, and highlight best practices for conference content and engaging with healthcare professionals. The episode covers crafting social media policies, the importance of social listening, and effective monitoring tools. It concludes with insights on adverse event reporting and maintaining integrity, along with expressions of gratitude.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show.

0:00Hey, guys. Welcome to the podcast. Have an exciting topic and an exciting guest to share with you today, Carl DeLuca. Carl and I have gotten to know each other from seeing each other at conferences, and we kinda kicked this idea around. And I kinda been you know, I've been hounding him for a while to kinda get him to come on, and I'm I'm really excited that I get to share him with you guys. So, Carl, welcome to the podcast. Thanks, Tom. Happy to be on. Yeah. Why don't we start with an intro if you wanna just introduce yourself and who you are, where

0:32you're from, all that good stuff. Sure. So I am Carl DeLuca. I am a scientist by training. I work at Regeneron Pharmaceuticals. I'm in oncology medical affairs, and my role is basically director of insights and analytics, for medical affairs. So kind of embracing all things digital. And so social media is actually one of those channels that we we are proving. So, yeah, happy to be on. Yeah. And we're gonna so we're gonna talk about social media and compliance and what MSLs need

1:07to know. Before we get to that, we do have a sponsor today. Our episode is sponsored by our dear friends at Medical Watch. So if you guys remember, we've talked about how awesome Medical Watch is. They help you understand what HCPs are saying about your products and diseases on social media. So you definitely wanna sign up. Check it out. Go to medical.watch. Sign up is free. Carl just signed up.

1:37He's he's the newest, Medical Watch, subscriber, so we invite you to to sign up as well. Yeah. I'm happy to play with it too. Yeah. Awesome. So, let's jump into it. Social media is a I mean, it's a hot topic, man. Everybody's trying to figure it out and and see how it fits into, each and every space. It's tricky when we talk about medical affairs. So that's why I think it's this is gonna be an important topic. So let's start by setting the stage.

2:09When it comes to social media, what are some of the main compliance considerations MSLs need to be aware of? Yeah. I would say probably the main ones is what your company policy is on, you know, MSLs being on social media as representatives of the company. I know I I can't speak to personal accounts, but if you're an MSL and you list Regeneron or whatever company you work for as your employer, then you're their representative.

2:39And it's doesn't matter what time of day. It's the weekend. Twenty four seven, you know, you're representing your company. So if you're posting things or commenting that you wouldn't do, you know, in a conversation with an ACP, then you shouldn't be doing it on social media. I I think that's how I would say it. And and and from a perspective of, you know, what to say, what not to say, I mean, I take the front page test. So which is if this was on the front page of The New York Times, would I be embarrassed, and would this company be in trouble because of what I say?

3:11So that's how I I use it. I mean, it's common sense, but if your company has specific policies, I highly recommend you follow those. Yeah. I think there's there's there definitely should be the does is there some does this feel uncomfortable? It does is is what I'm about to post make me pause? And if so, maybe I should. Is that the sentiment?

3:43Is is do MSLs need to fully and always be aware of the importance of respect, respecting compliance guardrails, before they even start developing the content and posting the content. Yeah. Absolutely. And I think what's probably more important than just your policies, I mean, those should be the background, but your scientific credibility. If you you know, you're on social media and you're commenting on a competitor and you're

4:17being derogatory or, you know, doing something that you shouldn't be doing, then I think your social your your credibility takes a hit. So, basically, then you're instead of being a scientific voice, you know, a disease state you kind of are thought of as kind of a company shell. So I also use that as a kind of a the backbone to my involvement in social media. I try to minimize it, especially on different link you know, like, Med Twitter. I'm I'm not on there. But, you know, LinkedIn, if I see something interesting, I'll like it.

4:50Mhmm. But understand that liking something is also a tested endorsement. So if you're liking things, you also have to consider that as a company representative, you're endorsing it. So that's it's tricky. I mean, it's you know? And nothing is private anymore. So if if you're doing something on social media, it could come back to haunt you. And I think that that I think what you just said is interesting because I think a lot of times people don't they don't make the disconnect. They don't recognize that they their personal brand is tied to your corporate brand.

5:27So if you're out there liking and sharing and commenting, you're doing that not just on your own behalf, but it's on behalf of the company as well. Is that is that kinda what you're saying? Exactly. Yeah. Yeah. So you're representing your company twenty four seven. You know, if if you, like, have a LinkedIn account and, you know, you include your employer, I mean, by association, you're representing your your employer. And so if you're an MSL and that's in your title, then assume that's how you're behaving

5:57online. I think there's probably a lot of people that don't even realize they're crossing the line or maybe you're doing something they shouldn't. There's an ignorance to it, maybe. In your experience, how how how much misconception and and how much misguidance is there with MSLs as it relates to, like, what's allowed, what's not allowed?

6:28I think there's a lot of misconceptions. I I I think probably the biggest one is that it's your opinion, and it's not. And if you're a comp if you're, like I said, representing your company, all that's discoverable. So if there's ever a problem, your social media posts will basically become evidence if if if they need to be. I mean, obviously, those are dire situations, but the FDA doesn't make any distinction. You know, if you're violating, you know, FDA rules by being promotional, you know, off label content, then you are you know, you're responsible for that, and it's it's it's a bad

7:04look. Yeah. Yeah. Again, I really think that this is I think people need to get better at and need to pay attention. Yeah. How's The perception is everything. You know? If I give even if you're not being unbalanced or you're not being promotional, but it's can be perceived as promotional, again, that's another hit to your credibility. Well, let's talk about that too because I think I think MSLs may be challenged distinguishing

7:37between scientific exchange and promotional activity, like, when they're sharing, content or commenting on content. So let's talk about that a little bit. Yeah. So if I mean, I I think, you know, if you're liking your company's, you know, posts, they can be it's considered promotional. You know what I mean? So even though it's it's not really promotional, it is considered that. It's an endorsement of it.

8:08So that's you know, I I think where it gets tricky, and that's where there's a lot of it's a it's a gray area too. So it's not always cut and dry. Each company has their own policies, so just be be wary of I mean, be mindful of what your company's policies are. And, also, even your personal social media account. You know, if if your, you know, perception on your personal, you know, account feeds into all of this. You know? It's like it's that is not shielded from your employer. So it's yeah.

8:38I mean, if you're talking to, you know, people online about your product, even as your personal account, you know, that could, you know, definitely raise alarm bells. Yeah. I'd love to get your opinion. Let's let's like, what not even opinion, but, like, you're you're an expert in this space. What would be some clear examples of what would be considered compliant versus noncompliant social media behavior in for field medical professionals?

9:12Yeah. So I would say, if you preface something with this is my personal view, that's, that is it doesn't matter that you say that. That that's irrelevant. So, you know, saying that something is your own opinion and does not represent your employer, that that carries no weight. And, know, sharing a published page paper may seem harmless, but amplifying a certain, you know, data itself is a form of of messaging.

9:45So it's considered, you know, promoting something. So if it's an off label indication or even if it's your indication, you're considered promotional. So, I mean, those are those are some common myths. Like I said, liking and resharing are not neutral. They're promotional. They're an endorsement. Yeah. I'm sure there's other examples, but I think those are probably the most common liking and resharing. If you're engaging in, you know, an argument with a a KOL online, you know, that's you're

10:17representing your company. You know, if you're having a scientific discussion, you know, and it's that's that you're basically representing your company. So you have to be very, very careful. It's not to say that you can't engage scientifically, but you have to remain neutral in disease state. So is it, I mean, getting back to what you just said, so is it a thing? Like, do people think that if, like, they just say, these are not my opinions, or these are my opinions, they just let it rip and they and it's okay?

10:48Like, is that because that I think that that's there's that should really we should kinda stop and talk about that a second because maybe that's a misconception that people just think that they get it's like a get out of jail free card. As long as I say this, then I'm covered. Yeah. No. It's not. I mean, I don't think that the the the FDA or any your company cares that you say that. I mean, it's the same thing if you were walking to someone's office and say, well, this is my personal opinion. The competitor sucks.

11:18That you you're still you still are, you know, representing your company. So by this you know, putting that disclaimer in front of it doesn't change the fact of what you said. So your company would, you know, would would consider it still probably not something that you should be doing. Yeah. It's not a it's not a get out of jail free card. Yeah. Yeah. Well, again, that's, you know, the best way I could kinda describe it, the with the based upon what you were saying. Yeah. What are your thoughts on dark posting?

11:51So targeted content, and how it's geofenced here in The US. Yeah. So I'm pretty neutral about dark posting. So from from what I understand, you you can you can post something and have it targeted toward, let's say, physicians without targeting without, you know, broadcasting it to the general public. So if you post so, like, your company posts something and physicians get it, a dark post

12:21would be that it doesn't show up on their main feed. So on the company main feed, that particular post is not there, but it has been posted to select accounts based on, you know, demographics, you know, career, whatever it is that they use to to target, you know, whomever they're they're reaching. And as far as, like, geofencing, I mean, that's one way to kind of not to get into regulatory mess in that if your indications are not you know, you we don't have the same rules in The

12:52US as, let's say, France. So you can't, you know, send American messages to France, and French physicians can't come to The US and, you know, can't actually access, you know, this content. So geofencing kinda protects the company. Mhmm. But there are ways to get around it. I mean, a a VPN, you know, will will basically kinda get rid of the geofence because it puts you in that country. So it's not foolproof, but it's it's a good measure for companies to kind of protect their

13:23reputation also. And, you know, and also for the targeting is, like, you know, you you wanna target the people that will make a difference, and you don't wanna target, let's say, patients, you know, with medical information they may or may not understand. So I I think it's it's a relatively good thing. But yeah. I mean, I think having the the name dark posting makes it sound a little sinister. Mhmm. I don't think it's sinister. I just think that, you know, it's just a it's a way of communicating that's very refined Yeah. In target.

13:53Yeah. What about conference content? Let's talk about, like, best practices for posting and engaging with conference content as it relates to data, posters, abstracts, that sort of thing. Yeah. So the one rule is, obviously, if something is embargoed and, you know, this happens all the time. It's like, you obviously shouldn't be sharing it on social media. That could definitely get you in trouble. But, also, the same rules apply. You know? If, you know, your competitor, you know, fails, you know, whatever a phase one test or, you

14:29know, a phase three trial and they don't get, you know, the results they want and you post that with, you know, comment to say, like, other you know, their molecule was garbage from the beginning, then that's definitely, you know, considered something that you shouldn't do. Promoting you know, like, for instance, with my company, we have a a medical affairs LinkedIn, and we're actually allowed to kinda repost some of those those that content either from a meeting or, like, a press release or something because it's gone through kind of regulatory

15:01review, and so the company is deemed that safe. So from that perspective, you know, when I'm at a conference, I don't post things that are not, you know, approved by our regulatory team. So I just basically kinda forward out, you know, the post that we deem fine, you know, through our communications team and as well as our regulatory team. It's just a safer that way. It's not to say that you can't comment on science, but comment in a in a in a neutral way and, you know, keep a disease state.

15:33You know? We're scientific. I mean, just don't don't talk about, like, obviously, commercial implications or comparative analysis. You know? Don't say it's like, well, this drug, you know, we knew it wasn't any good anyway because it doesn't target the receptor of interest. While that's scientific, that's also seen as being biased. You know? So, yeah, what you wouldn't say in a meeting is holds true for what you wouldn't say on social media. So if you wouldn't say that to a physician because then he would think maybe that you're

16:04basically a company shell, then I I wouldn't I wouldn't do it. Do you do does that like, do you feel like people sometimes the I I feel like, personally, people hide behind social media and do and say things that they wouldn't normally say Yeah. To someone's face. Like, you know, what what is in ex you know, unacceptable to someone in one way, you can kinda hide behind social media.

16:35Is that what you're saying? Do you feel like sometimes people kinda get a little too lax when it comes to social media and should be I don't I don't know if I'm just stretching this, but I you just said something that made me think that maybe people get a little too comfortable on social media. Yeah. I I think they do comfortable from a standpoint. It's like they feel like they're engaging in scientific exchange. And maybe on the surface, it looks like that, but it could be perceived by your employer as not being, you know, balanced, not being, you know, acceptable behavior.

17:09As far as, you know, hiding on social media, I think when you have anonymity, yes, that is absolutely the case. But when you like, something on LinkedIn, yeah, I find that that's less the case. I think LinkedIn is and I think the the FDA views it as differently as well. You know, Twitter versus LinkedIn. I mean, obviously, this LinkedIn is a safer venue for that. But yeah. So, and you can't be anonymous on LinkedIn. So but, like, say, like, on Twitter, you assume a pseudonym and trash the competitor.

17:42I mean, will you ever be found out? Maybe maybe not. But, yeah, I I think people are braver online, but unless your name is attached to it. If your name is attached, I think people tend to be less inflammatory. So what's your advice for MSLs on how they should handle connections and interactions with HCPs and KOLs Yeah. On social media while remaining compliant in those interactions? So the first thing I would say is check with your company policy on what is acceptable

18:15behavior online. If you know? Because, I mean, it is it's not a bad thing to build up a social media presence. You know? It's like as an MSO, you want to be recognized as a disease state expert. You know? Not not just on, you know, your product, but the disease and the treatment landscape. You you are a source for information, but you don't wanna muddy that perception with bias and, you know, and that's easy to do. So let's say, you know, social media policy. And, also, I mean, think about what you're saying.

18:49You know? Is it something that if, you know, was leaked to your boss, you know, your boss sees it, would he question kinda why you did such a thing? So the the way I always, you know, think about things is if this was sent to my manager or if this was sent to, you know, legal and compliance, would they be like, oh, this is fine? You know? Then it but if they were like, this one, you know, kinda crosses the line and you know when you've crossed the line, I think. You know? So, you know, stick to the facts, stick to the science, try not to, you know, talk

19:22commercially, and also try not to denigrate competitors. I mean, that's the big tell for someone being biased. Yeah. Well, you know, you bring up a good point. I think, you know, it's so important to you know, everybody's on social media now. And Yeah. You talk about LinkedIn and Twitter, some of the things that are more widely accepted in the professional world. But, I'd love to get your thoughts on personal branding for medical affairs professionals and

19:53MSLs and how they can go about building their brand and being visible and being subject matter experts, but also doing it in a compliant way. Oh, absolutely. So, I mean, for instance, if you're, you know, your disease status, say, you know, oncology or whatever, and you can totally build your brand as a scientific expert by posting, you know, trials that are not necessarily trials, but, you know, papers that speak to pathway and kind

20:25of the the possibilities as opposed to, you know, speaking about a specific drug or something that's in commercial development. So I would say stay away from, you know, the pharma part of it and focus on the science part of it. That that would say that's probably the the the best way to build your brand because, I guess, what is your brand? What do you want it to be? Do you want it to be scientific expert, or do you want it to be pharmaceutical rep? You know? For me, it would be to be a scientific expert.

20:56Because above all, you know, you're a scientist, you know, and and that's what you want your personal brand to be. So I always keep it, you know, as as clean as possible. You know, if I'm talking about, like you know, let's say I'm talking about obesity and, you know, I'm talking about, you know, different neuroendocrine pathways, that's fantastic because there's nothing about that that's commercial. You know, maybe there's some commercial activity, you know, around certain receptors or certain pathways, but keep it science, and then you're fine. And you I think you build a reputation of being, you know, scientific and being somebody

21:32with a reputation that's solid. I think there's a lot of companies out there that are trying to figure this whole thing out. I think that you had said, you know, before check with your company policy, check with internal guidelines. I think there's a lot of companies right now that are they're still they're still defining it. So what what would you say to those people? Like, medical affairs leaders and people that are setting the strategy and setting the tone and setting the guidelines and the policies, what advice do you have for them as they're

22:05doing that? Yeah. I would say, for for the people that would be setting up the policy. Yeah. Yeah. I would say try to balance the ability to somebody for somebody to build their personal brand on, you know, social media as, you know, a medical expert, a scientific expert, and also, you know, make it such that the company is protected and from liability. So make sure that nobody's posting things that they don't want you to post.

22:37You know? If it's goes against your regulatory in compliance, then I would recommend that, obviously, train your teams. You know, what are the guardrails? You know? What can you post? What can't you post? That's what my company does that. They lay it out very clearly. You can post from our LinkedIn, site and repost those. But, you know, other other places or other posts, that's kind of a gray zone, and so you have to use your best judgment.

23:08If you think that you're gonna be viewed as somebody who's, you know, biased, then you probably shouldn't post it. Because, I mean, ultimately, in the end, it's protecting your reputation. You know? And if and if you're doing things that might see you on tour or you know? I don't know. Yeah, controversial Mhmm. Then you probably shouldn't do it. Yeah. What about and and, you know, there's I think everyone's pretty much in agreement that social

23:43media has become an important part of our our jobs in in our brand and whether it's personal brand or professional brand. But there's also other reasons why we need to be involved in social media, and that is to see what's going on, to hear what's going on, not just as a an active tool of posting, but also as a passive tool, listening and and researching.

24:15So talk a little bit about the importance of the social listening aspect. Oh, absolutely. I think that's probably 10 times more important than, you know, interacting on online is listening to what your customers have to say. So pulling that information from, you know, Blue Sky, from x, from whatever, you know, platform, you know, Even the Doximity, if they ever let, you know, you access their information, which is a social media for for licensed physicians, that information is gold.

24:51You know? It it is you're looking at kind of, like, what are people talking about in your disease space and being candid about it. And so to be able to to analyze that information to inform your strategy, I think, is the best use of social media. I mean, being active in social media, if that's what you wanna do, that's great. Just follow the rules. But I think pulling information from social media to inform medical strategy, that that's golden. You know? Because physicians, you know, are are pretty frank, you know, and scientists are pretty

25:21frank when they're on social media in terms of, you know, drugs and pathways and why is this company, you know, developing a me too drug, blah blah blah. You know, we think that you know? And it it basically allows you to kind of form your strategy around that. If you're being perceived as a me too, well, then maybe your your messaging or your medical messaging should be you know, these are the differentiators between us and what, you know, our competitor competitors are. Yeah. So it it allows you to see what people are saying that they wouldn't normally say to your,

25:52you know, your field medical people or your medical directors because it's like you said, it's a little easier to do it on social media. You know? I've had conversations with people in person who trash us on social media And you know? But then when you talk to them, they're much more docile, and they don't really say it the way they said it on social media. So I think you get a different type of information from social media than you get from, like, a conversation with that person. And you're right.

26:22People I mean, it's easier to be critical behind a computer screen than it is to be, you know, in in person with that with somebody from the company. But I think you bring up a good point. I think this this whole conversation shows the importance of, you know, being aware. What if you weren't aware that your HCPs, your KOLs are trashing you in some way, or there's there's some type of misconception or just an attitude that you can pick up on?

26:54What if you weren't aware of that? I think that one of the important pieces of of social listening or or being active on social media is to you know, we talk we hear about MSL should be the CEO of their territory. Well, that means you have to know you have to be an expert. You have to know all there is to know. Right? I mean, otherwise, you're missing a piece. No. Absolutely. And there's you know, there are applications that and platforms people use to to basically

27:24do that. You know, there's, like, Monocle. There's Quello. There's you know, there are, you know, providers that basically allow you to monitor your social media. For your specific drug, you can, you know, highlight physicians that you wanna follow, and it gives you updates on how they're interacting with posts, what they're posting, who they're sharing to, how many you know, what the activity on their posts are. So I think, you know, social media definitely shines when it comes to gathering information

27:55because it really truly informs you and informs your strategy so you're not flying blind. Now it it could be that, you know, there's a competitor that's coming out and everybody's really excited about it. You wouldn't know this because the drug's not approved yet. But if you go to social media, it's like everybody's talking about this particular, you know, specific pathway, and they're really, you know, excited about it, you should know that, you know, if it def if they're a direct competitor. So, definitely, I I think you get a lot more information, not just from, you know, the the

28:26big KOLs, you know, the the academic KOLs, but from everybody, from community physicians, from, you know, you know, hospital physicians. You you get kind of a a cross section of the medical community who you'll be basically servicing. So, yeah, it's it's I I think it democratizes information, and that's a good thing, you know, especially for for pharmaceutical companies. Yeah. I had someone on the show one time who said that he was having a similar conversation. He said that he went into a KOL's office with a very specific agenda, and, the KOL just was

29:02stone faced. And then it was just like, did you even did did you even look to see the latest paper that I just published? Because, like, he clearly missed what he should have started with, which was that this guy just published something on that. I forget the exact situation, but think about that. Right? Oh, yeah. No. And they expect you to I mean, some ex especially younger physicians that they I think they expect you to know that. Yeah. You know, they they think there's an expectation that you you know what they're what

29:33they're doing on social media and knowing what they're publishing. Yeah. That's I mean, I think that's, you know, good practice for any, you know, MSL is, you know, before you go into a meeting with somebody, absolutely know everything that's going on with them, you know, so that you can speak to them. Yeah. And like you said, there's tools out there. Shout out to Medical Watch. Check out Medical Watch. That's what it's for. It's an awesome social listening tool. I've used it. I know you're you know, you just started using it. So, check that out.

30:04And and, Carl, before we before we kinda wrap up wrap. Share any I think that's a great pro tip, you know, getting into social listening tools. But another like, what are some other pro tips that you wanna share with MSLs as it relates to social media and compliant use of social media and guardrails and and that sort of thing? Yeah. The one thing that we didn't touch upon, which I think is very important, is the social from a

30:34social media perspective. When you engage somebody, on social media, rules of adverse event reporting don't go away. So what you what you, you know, you should be mindful of is when you are posting and you're starting to get replies and maybe people are mentioning adverse events, those things have to be reported. So, you know, it causes a huge, you know, resource strain on the company if they're, you know, looking at, let's say, you know, a Reddit post and, like, hundreds of people are complaining about their drug.

31:05They have to report that. You know? So be mindful of what you're putting out there that doesn't attract something that's going to cause your company more work. You know? So that's the other, you know, suggestion I have is don't open up a can of worms that doesn't need to be opened up. You know? You we wanna hear about adverse events, obviously, but we there has to be a quality to it. You know, just kind of letting loose, you know, on online about a a drug, you know, you're gonna get stuff in there that's not necessarily germane or real.

31:39So I would say, you know, avoid minefields that you could, you know, you can lay down. Yeah. And the other the other piece of advice is just, you know, protect your integrity. You know? Protect your, you know, your reputation as a scientific expert. Good advice, man. We'll leave it there. Carl, you were awesome. I that was man, that went fast. That was a great conversation. I learned a lot. I hope you guys did as well. So as always, if you got a lot out of this, please share this with others.

32:11I appreciate all your support. Love you guys, and I'll see you next time. Thanks again, Carl. Thank you, Tom. It was a pleasure.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. The Wrong Voices: How Bad Mentors Can Ruin Your Career

    Nov 17, 202628 minVideo

    What qualifies someone to influence your future? Tom Caravela explains why career guidance should be filtered through relevant experience, current knowledge, credibility, and objectivity. He examines the risks of...

    Listen to the audio

    Credit the people on this episode

  2. Hidden Secret to Career Happiness and Longevity

    Nov 3, 202635 minVideo

    What turns an industry contact into a long-term ally? In this episode, Tom Caravela and Ed Doherty look beyond transactional networking to the genuine friendships that can shape a career in medical affairs. They discuss...

    Listen to the audio

    Credit the people on this episode

  3. How to AI-Proof Your Career: The 4 Pillars of Career Success

    Oct 20, 202623 minVideo

    Becoming undeniable is Tom Caravela’s answer to building career security in the age of AI. He breaks down four pillars you can control: skills, experience, relationships, and brand. Tom explains how continuous learning...

    Listen to the audio

    Credit the people on this episode

  4. How Medical Affairs Influences Decisions that Matter

    Oct 13, 202638 minVideo

    What happens after an MSL submits an insight? In this episode, Tom Caravela and Cameron Tew examine how field observations create value only when organizations decide what to do next. They discuss shared definitions,...

    Listen to the audio

    Credit the people on this episode

  5. Stop Being Your Own Worst Enemy

    Sep 29, 202619 minVideo

    In this episode, Tom Caravela discusses common mindset traps that can hold Medical Science Liaisons and aspiring MSLs back. He covers how to move past worst-case thinking, overanalysis, concern about others’ opinions,...

    Listen to the audio

    Credit the people on this episode